Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schratzberger, G.
Right arrow Articles by Mayer, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schratzberger, G.
Right arrow Articles by Mayer, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 1384-1390
© 2002 European Renal Association-European Dialysis and Transplant Association


Invited Comment

Chronic allograft failure: a disease we don't understand and can't cure?

Gabriele Schratzberger and Gert Mayer

Division of Nephrology, Department of Internal Medicine, Anichstrasse 35, A-6020 Innsbruck, Austria

Keywords: donor; kidney transplant; nephropathy; recipient

The first 150 words of the full text of this article appear below.

During recent decades many new and successful strategies have been developed to improve 1-year renal allograft survival rates. It has become evident, however, that graft loss after the first year has not been reduced by the same magnitude. A high percentage of transplanted kidneys develop dysfunction in the first few months post-transplantation and ultimately fail, despite the use of modern immunosuppressive regimens. This type of graft failure has been termed chronic rejection. However, as both immune and non-immune mechanisms seem to contribute to its pathogenesis, the term currently used is chronic allograft nephropathy (CAN). The concept of chronic rejection slowly emerged in the 1950s and 1960s. Acute rejection was well known in the late 1950s, but even then only few kidneys survived for months. Initially Hume et al. [1], and later Porter et al. [2] and Jeannet et al. [3], reported arterial intimal . . . [Full Text of this Article]

Recipient factors

Recipient age
Recipient blood pressure at time of transplantation
Recipient renal function status
Recipient sex, race, body mass index and native kidney disease
Number of previous transplants, pre-transplant pregnancies, pre-transplant transfusions and peak panel reactive antibodies
Donor factors

Donor age and donor type
Type of donor death and medical history of the donor
Combined recipient/donor factors

HLA matching
Organ preservation time
Delayed graft function
Acute rejection
Type of maintenance immunosuppression
Miscellaneous factors

Blood pressure post-transplantation
The search for a unifying hypothesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
B. Ivanyi
Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers of chronic renal allograft rejection
Nephrol. Dial. Transplant., April 1, 2003; 18(4): 655 - 660.
[Full Text] [PDF]